Patent AnalyticsExaminers
Menu

Topic

Macular degeneration Steady

440 applications whose title mentions it. Its share of new filings over the last two years is 2% above the four years before.

Allowance rate
46%
−29 pts vs the USPTO 366 decided
Months to first action
18.0 mo
−0.6 vs the USPTO
Applications
440.0
in the record
Allowed
170.0
196 abandoned

Filings by year

How often the topic was filed

The most recent years are still filling in.

Who files it

Companies and institutions

Bars show the share of decided applications that were allowed.

Unlock the filers behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Applications

Recent applications on this topic

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19883461Drug Treatment for Macular Degeneration2026-10-08Pending00n/a
19613830Contact Lens for Use in the Treatment of Macular Degeneration Associated Disease2026-08-10Pending00n/a
19590208NOVEL PEPTIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING …2026-05-22Pending00n/a
15578418Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15985444Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15107420Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15362588Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15746044Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15985098Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15510469Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock every application on this topic, with its timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in